'It is tremendously gratifying that our discovery is being upheld by so many other groups around the world. This firmly establishes that a skin barrier defect underlies eczema and related conditions and importantly, sets the scene for the development of new and more effective treatments', said Professor McLean.
At a genetics meeting this week, Professor Richard Trembath, of King's College London, will report on the incredibly strong association of the filaggrin gene mutations they have found in the English population, in collaboration with the Dundee group. The data from the English study suggests that filaggrin mutations are carried by almost half of adults who have had severe eczema since childhood. This sheds light on the type of eczema conferred by this gene, that is to say, it may be appear early in childhood, is more severe, and may persist into adulthood.
At the same conference, Professor McLean will present a further study in the Irish population of early onset eczema. The McLean group have now identified further defects in the gene that are also present in the general population. About 48 per cent of Irish cases of moderate to severe eczema carry one of five known defects in the filaggrin gene.
A major problem encountered in the study of common disorders with a genetic component, such as eczema, is that one laboratory finds an association of the gene with the disease in question but others fail to duplicate the result in other populations and/or using other genetics methods. Fortunately, the filaggrin gene story is turning out to be very different.
In the original report from the McLean group, there were already a number of duplicate studies in the Irish, Scottish and Danish populations. Since that time, the Dundee group, with their collaborator Dr Alan Irvine in Dublin, have reported further replication studies in the Irish and Southern German populations by a variety of methods. Two further independent papers from research groups in Germany have also been published, again confirming the role of this gene in eczema. These studies, in addition to those already published by the McLean/Irvine group and those emerging from other laboratories around the world, bring the total number of positive replications to about twenty and strongly establish filaggrin as an important gene in eczema and related allergic conditions, such as eczema-associated asthma.
The McLean laboratory, at the Human Genetics Unit, University of Dundee, discovered that up to 10 per cent of people in European populations carry mutations that essentially 'knock out' or 'switch off' the filaggrin gene.
This gene normally makes large amounts of filaggrin protein in the outermost layers of the epidermis. This protein is essential for maintaining skin barrier function that prevents the skin drying out and also prevents the entry of foreign substances into the body. The gene is also linked to a form of asthma that accompanies eczema in patients, as well as a number of other allergic symptoms, including eczema-associated hay fever.
Professor McLean and Professor Trembath with present their results at the annual meeting of the British Society of Human Genetics, being held at the University of York from 18-20th September.
Anna Day | alfa
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine